Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Pei, Duanqing  [Clear All Filters]
2024
Li C, Xu X, Chen S, Xu A, Guan T, Wu H, Pei D, Liu J. Epigenetic reshaping through damage: promoting cell fate transition by BrdU and IdU incorporation. Cell Biosci. 2024;14(1):9.
Kuang J, Li P, Zhai Z, Fan Y, Xu H, Zhao C, Li W, Li X, Liang Z, Huang T, et al. Exclusion of HDAC1/2 complexes by oncogenic nuclear condensates. Mol Cancer. 2024;23(1):85.
Zhao Y, Chen S, Liu X, Chen X, Yang D, Zhang J, Wu D, Zhang Y, Xie S, Li X, et al. Single-cell RNA-seq of in vitro expanded cells from cranial neural crest reveals a rare odontogenic sub-population. Cell Prolif. 2024:e13598.
2023
Li D, Luo L, Guo L, Wu C, Zhang R, Peng Y, Wu M, Kuang J, Li Y, Zhang Y, et al. c-Jun as a one-way valve at the naive to primed interface. Cell Biosci. 2023;13(1):191.
Zhong H, Zhang R, Li G, Huang P, Zhang Y, Zhu J, Kuang J, Hutchins AP, Qin D, Zhu P, et al. c-JUN is a barrier in hESC to cardiomyocyte transition. Life Sci Alliance. 2023;6(11).
Hao C, Chu S, Quan X, Zhou T, Shi J, Huang X, Wu G, Tortorella MDaniel, Pei D. Establishing extended pluripotent stem cells from human urine cells. Cell Biosci. 2023;13(1):88.
He L, Shi H, Zhang G, Peng Y, Ghosh A, Zhang M, Hu X, Liu C, Shao Y, Wang S, et al. A Novel CCK Receptor GPR173 Mediates Potentiation of GABAergic Inhibition. J Neurosci. 2023.
Wang B, Li C, Ming J, Wu L, Fang S, Huang Y, Lin L, Liu H, Kuang J, Zhao C, et al. The NuRD complex cooperates with SALL4 to orchestrate reprogramming. Nat Commun. 2023;14(1):2846.
Cao S, Feng H, Yi H, Pan M, Lin L, Zhang YSanto, Feng Z, Liang W, Cai B, Li Q, et al. Single-cell RNA sequencing reveals the developmental program underlying proximal-distal patterning of the human lung at the embryonic stage. Cell Res. 2023.
Liang L, He M, Zhang Y, Wang C, Qin Z, Li Q, Yang T, Meng F, Zhou Y, Ge H, et al. Unraveling the 2,3-diketo-L-gulonic acid-dependent and -independent impacts of L-ascorbic acid on somatic cell reprogramming. Cell Biosci. 2023;13(1):218.
2022
He S, Sun H, Lin L, Zhang Y, Chen J, Liang L, Li Y, Zhang M, Yang X, Wang X, et al. Correction: Passive DNA demethylation preferentially up-regulates pluripotency-related genes and facilitates the generation of induced pluripotent stem cells. J Biol Chem. 2022;298(11):102566.
Huang J, Yang X, Wang J, Wu H, Pei D, Chen J. Fast and Efficient Mouse Pluripotency Reprogramming Using a Chemically-Defined Medium. Methods Protoc. 2022;5(2).
Fan Y, Zhang Y, Shi K, Cheng S, Pei D, Shu X. Identification of a group of bisbenzylisoquinoline (BBIQ) compounds as ferroptosis inhibitors. Cell Death Dis. 2022;13(11):1000.
Leung AOn-Wah, Yiu T-C, Liu L, Tam H-Y, Gu S, Tu J, Pei D, Cheung H-H. Targeting G-quadruplex for rescuing impaired chondrogenesis in WRN-deficient stem cells. Cell Biosci. 2022;12(1):212.
2021
Xing G, Liu Z, Huang L, Zhao D, Wang T, Yuan H, Wu Y, Li L, Long Q, Zhou Y, et al. Correction to: MAP2K6 remodels chromatin and facilitates reprogramming by activating Gatad2b-phosphorylation dependent heterochromatin loosening. Cell Death Differ. 2021.
Fu Y, Shan Y, Zhang M, Pei D. Phase separating cell fate. Cell Stem Cell. 2021;28(10):1677-1678.
2020
Wu K, Liu H, Wang Y, He J, Xu S, Chen Y, Kuang J, Liu J, Guo L, Li D, et al. SETDB1-Mediated Cell Fate Transition between 2C-Like and Pluripotent States. Cell Rep. 2020;30(1):25-36.e6.
2019
Zhao R, Cheng L, Jiang Z, Wei X, Li B, Wu Q, Wang S, Lin S, Long Y, Zhang X, et al. DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells. Oncoimmunology. 2019;8(1):e1509173.
Wang B, Wu L, Li D, Liu Y, Guo J, Li C, Yao Y, Wang Y, Zhao G, Wang X, et al. Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4. Cell Rep. 2019;27(12):3473-3485.e5.
2016
Sipp D, Pei D. Bioethics in China: No wild east. Nature. 2016;534(7608):465-467.
Ye W, Jiang Z, Lu X, Ren X, Deng M, Lin S, Xiao Y, Lin S, Wang S, Li B, et al. GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathways. Oncotarget. 2016.
Zheng Y, Jia L, Liu P, Yang D, Hu W, Chen S, Zhao Y, Cai J, Pei D, Ge L, et al. Insight into the maintenance of odontogenic potential in mouse dental mesenchymal cells based on transcriptomic analysis. PeerJ. 2016;4:e1684.
Zhou P, Wu F, Zhou T, Cai X, Zhang S, Zhang X, Li Q, Li Y, Zheng Y, Wang M, et al. Simple and versatile synthetic polydopamine-based surface supports reprogramming of human somatic cells and long-term self-renewal of human pluripotent stem cells under defined conditions. Biomaterials. 2016;87:1-17.
2015
Wang M, Deng Y, Zhou P, Luo Z, Li Q, Xie B, Zhang X, Chen T, Pei D, Tang Z, et al. In Vitro Culture and Directed Osteogenic Differentiation of Human Pluripotent Stem Cells on Peptides-Decorated Two Dimensional Microenvironment. ACS Appl Mater Interfaces. 2015.
Liu J, Han Q, Peng T, Peng M, Wei B, Li D, Wang X, Yu S, Yang J, Cao S, et al. The oncogene c-Jun impedes somatic cell reprogramming. Nat Cell Biol. 2015.

Pages